Found: 17
Select item for more details and to access through your institution.
No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
- Published in:
- Depression & Anxiety (1091-4269), 2010, v. 27, n. 5, p. 417, doi. 10.1002/da.20695
- By:
- Publication type:
- Article
Estimating the Total Number of Alleles Using a Sample Coverage Method.
- Published in:
- Genetics, 2001, v. 159, n. 3, p. 1365, doi. 10.1093/genetics/159.3.1365
- By:
- Publication type:
- Article
A placebo-controlled, ascending, multiple-dose study to evaluate the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-708163 in healthy young and elderly subjects
- Published in:
- 2010
- By:
- Publication type:
- Abstract
The safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of BMS-708163 in young and elderly subjects
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Effect of concomitant administration of multiple doses of BMS-708163 on safety, tolerability, and the pharmacokinetics of midazolam, warfarin, caffeine, omeprazole, and dextromethorphan in healthy male subjects by administration of a modified Cooperstown cocktail
- Published in:
- 2010
- By:
- Publication type:
- Abstract
A study to evaluate the effects of single oral doses of BMS-708163 in the cerebrospinal fluid of healthy young men
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1–Infected Subjects.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 7, p. 1002, doi. 10.1093/infdis/jis432
- By:
- Publication type:
- Article
A Pooled Analysis of Pharmacokinetic Variability Information for Common Probe Substrates Used in Drug-Drug Interaction Studies.
- Published in:
- Pharmacology, 2018, v. 101, n. 3/4, p. 170, doi. 10.1159/000485516
- By:
- Publication type:
- Article
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 1, p. 136, doi. 10.1111/j.1365-2125.2012.04339.x
- By:
- Publication type:
- Article
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
- Published in:
- Liver International, 2016, v. 36, n. 2, p. 189, doi. 10.1111/liv.12964
- By:
- Publication type:
- Article
The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 9, p. 661, doi. 10.1007/s40261-014-0219-9
- By:
- Publication type:
- Article
Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 11, p. 761, doi. 10.1007/s40261-012-0006-4
- By:
- Publication type:
- Article
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 10, p. 695, doi. 10.1002/psp4.12227
- By:
- Publication type:
- Article
A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects.
- Published in:
- Clinical Pharmacokinetics, 2012, v. 51, n. 10, p. 681, doi. 10.1007/s40262-012-0005-x
- By:
- Publication type:
- Article
A Review of Daclatasvir Drug-Drug Interactions.
- Published in:
- 2016
- By:
- Publication type:
- journal article